NASDAQ:CELG - Celgene Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $87.57 +0.01 (+0.01 %) (As of 09/25/2018 04:00 PM ET)Previous Close$87.56Today's Range$87.46 - $89.1452-Week Range$74.13 - $147.17Volume3.99 million shsAverage Volume6.63 million shsMarket Capitalization$61.70 billionP/E Ratio12.98Dividend YieldN/ABeta1.33 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Celgene (NASDAQ:CELG) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.33 Wall Street analysts have issued ratings and price targets for Celgene in the last 12 months. Their average twelve-month price target is $122.8077, suggesting that the stock has a possible upside of 40.24%. The high price target for CELG is $166.00 and the low price target for CELG is $85.00. There are currently 1 sell rating, 12 hold ratings and 20 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.582.582.582.58Ratings Breakdown: 1 Sell Rating(s)12 Hold Rating(s)20 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)12 Hold Rating(s)20 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)12 Hold Rating(s)20 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)12 Hold Rating(s)17 Buy Rating(s)1 Strong Buy Rating(s)Consensus Price Target: $122.8077$122.8077$124.1321$127.2393Price Target Upside: 40.24% upside36.76% upside59.90% upside48.28% upsideCelgene (NASDAQ:CELG) Consensus Price Target History Celgene (NASDAQ:CELG) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails7/31/2018MizuhoReiterated RatingBuy$129.00Low7/27/2018SunTrust BanksReiterated RatingHold$101.00Low7/27/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$91.00 ➝ $93.00N/A7/10/2018CowenReiterated RatingBuy$150.00Low6/18/2018Standpoint ResearchUpgradeHold ➝ BuyLow6/1/2018Cantor FitzgeraldSet Price TargetHold$112.00Low5/30/2018Canaccord GenuityReiterated RatingBuyMedium5/23/2018ArgusDowngradeBuy ➝ HoldLow5/23/2018Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$102.00Low5/7/2018Leerink SwannReiterated RatingBuy$123.00 ➝ $115.00Medium5/7/2018Royal Bank of CanadaDowngradeTop Pick ➝ Outperform$120.00High5/6/2018BarclaysSet Price TargetBuy$107.00Medium5/5/2018Credit Suisse GroupSet Price TargetBuy$129.00Medium4/30/2018Evercore ISIReiterated RatingBuyLow3/26/2018Goldman Sachs GroupLower Price TargetSell ➝ Sell$97.00 ➝ $85.00Low3/21/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$110.00Low3/1/2018Robert W. BairdReiterated RatingHold$92.00Medium2/28/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$144.00 ➝ $139.00High2/28/2018William BlairReiterated RatingBuyHigh2/28/2018UBS GroupSet Price TargetBuy$106.00High2/28/2018Stifel NicolausReiterated RatingBuy ➝ Buy$130.00 ➝ $128.00High2/15/2018CannReiterated RatingBuy$163.00Low1/23/2018BTIG ResearchReiterated RatingHoldMedium1/18/2018Piper Jaffray CompaniesReiterated RatingHold$104.00Low1/10/2018GuggenheimReiterated RatingBuy$147.00Low1/8/2018Deutsche BankSet Price TargetHold$110.00Low1/8/2018OppenheimerSet Price TargetBuy$166.00High1/5/2018Bank of AmericaDowngradeBuy ➝ Neutral$104.68 ➝ $120.00Medium12/22/2017CitigroupReiterated RatingHoldMedium12/8/2017Atlantic SecuritiesUpgradeNeutral ➝ OverweightHigh10/27/2017JMP SecuritiesDowngradeOutperform ➝ Market PerformN/A10/26/2017Wells Fargo & CoDowngradeOutperform ➝ Market PerformN/A10/16/2017Jefferies Financial GroupReiterated RatingBuy$160.00N/A(Data available from 9/25/2016 forward) This page was last updated on 9/25/2018 by MarketBeat.com StaffFeatured Article: What is a Fiduciary?